All World Health Organization (WHO) and United Nations (UN) member states are committed to ending the tuberculosis (TB) epidemic.
The WHO's *Global Tuberculosis Report 2024* outlines a strategy for eradication through WHO schemes and the UN's Sustainable Development Goals (SDGs). This strategy, according to WHO, includes measuring achievements in 2020 and 2025, and targets for 2030 and 2035.
The WHO and UN are insistent on reducing the incidence of TB (new cases per 100,000 population per year), the absolute number of TB deaths, and the costs borne by people with TB and their households.
A 35% reduction in the absolute number of TB deaths compared to the 2015 baseline was recorded in 2020. This figure rose to 75% in 2025.
The target for death reduction is set at 90% in 2030 and 95% in 2035.
It should be noted that this mortality indicator counts the total number of TB deaths in both HIV-negative and HIV-positive individuals. The WHO states that TB deaths among people with HIV are officially classified as deaths caused by HIV/AIDS, with TB as the underlying cause.
Meanwhile, the achievement in reducing TB cases, using 2015 as a benchmark, was 20% in 2020. This figure also increased to 50% in 2025.
The target for case reduction is 80% in 2030 and 90% in 2035.
The WHO explains that the three pillars of TB control include: providing TB prevention, diagnosis, and treatment services within the context of progress towards universal health coverage (UHC); multisectoral actions to address the broader social and economic determinants of TB; and technological breakthroughs, such as new vaccines.
Another crucial target is that no TB-affected household should face catastrophic costs.
"This target is set in recognition of the fact that removing financial and economic barriers to accessing TB diagnosis and treatment is a prerequisite for achieving milestones and targets for reducing TB incidence and mortality," said the WHO, as quoted on Thursday (May 8, 2025).
This "catastrophe" encompassing the economic sector includes the total cost of direct and indirect medical expenses. Indirect expenses include loss of income due to the impact of the disease.
(Also read: Indonesia, the Second Largest Country with TB Cases Globally in 2023)